Garcia Danielle R, Souza Felipe R, Guimarães Ana P, Valis Martin, Pavelek Zbyšek, Kuca Kamil, Ramalho Teodorico C, França Tanos C C
Laboratory of Molecular Modeling Applied to Chemical and Biological Defense, Military Institute of Engineering, Praça General Tiburcio 80, Urca, Rio de Janeiro 22290-270, Brazil.
Department of Chemistry, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro 22541-041, Brazil.
Pharmaceuticals (Basel). 2021 Oct 9;14(10):1027. doi: 10.3390/ph14101027.
Continuing the work developed by our research group, in the present manuscript, we performed a theoretical study of 10 new structures derived from the antivirals cidofovir and ribavirin, as inhibitor prototypes for the enzyme thymidylate kinase from (TMPK). The proposed structures were subjected to docking calculations, molecular dynamics simulations, and free energy calculations, using the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method, inside the active sites of TMPK and human TMPK (TMPK). The docking and molecular dynamic studies pointed to structures 2, 3, 4, 6, and 9 as more selective towards TMPK. In addition, the free energy data calculated through the MM-PBSA method, corroborated these results. This suggests that these compounds are potential selective inhibitors of TMPK and, thus, can be considered as template molecules to be synthesized and experimentally evaluated against smallpox.
延续我们研究小组开展的工作,在本手稿中,我们对10种源自抗病毒药物西多福韦和利巴韦林的新结构进行了理论研究,这些结构作为来自[此处原文缺失具体物种]的胸苷酸激酶(TMPK)的抑制剂原型。使用分子力学泊松-玻尔兹曼表面积(MM-PBSA)方法,对所提出的结构在TMPK和人TMPK(TMPK)的活性位点内进行对接计算、分子动力学模拟和自由能计算。对接和分子动力学研究表明,结构2、3、4、6和9对TMPK具有更高的选择性。此外,通过MM-PBSA方法计算的自由能数据证实了这些结果。这表明这些化合物是TMPK的潜在选择性抑制剂,因此可被视为用于合成并针对天花进行实验评估的模板分子。